this paper is to review the etiology, diagnosis and new approaches to the treatment of chylopericardium. Here we present the case of a 30-year-old man diagnosed with a dysgerminoma with mediastinal involvement, who developed
Introduction
Chylopericardium is a rare entity characterized by the accumulation of chylous fluid in the pericardial sac. The pericardial cavity of healthy adults contains 25-30 cm 3 of a serous fluid which is nearly identical to lymph fluid [1] . An increase in this fluid may be secondary to various pathologies (trauma, surgery, irradiation of the mediastinum, mediastinal masses, infections...) or described as idiopathic.
Clinical case
A 30-year-old man was diagnosed as having a mediastinal dysgerminoma in October 1995. He presented with superior vena cava obstruction secondary to a large anterior mediastinal mass ( Figure 1 ) invading vascular structures (superior vena cava and pulmonary artery). At diagnosis, there was no pericardial involvement and staging showed no dissemination. Testicular ultrasonography results were normal and blood markers showed: LDH 569 U/ml; total HCG 111 mU/ml; oc-fetoprotein 6 mg/dl. Combination chemotherapy with PEB (cisplatinum 100 mg/m 2 i.v., day 1; etoposide 100 mg/m 2 i.v., days 1-5; bleomycin 15 U/12 hours i.v., days 1-5) was started, with cycles administered every 21 days. Following administration of the first cycle the patient clearly improved and after the second treatment, his dyspnoea completely resolved. Following three cycles of PEB the mass had shrunk by more than 50% on chest X-ray and the total HCG levels had decreased to 1 mU/ml, alpha-fetoprotein to 3 mg/dl and LDH to 143 U/ml. Two additional cycles without bleomycin were given.
Complaining of progressive dyspnoea and chest pain, the patient was admitted to the hospital for the fifth cycle. On physical examination, tachypnoea, jugular filling, generalized decrease of vesicular murmur and low cardiac tones without additional murmurs were found. He had no collateral circulation or peripheral oedema. ECG showed a sinus rhythm of 120 bpm, with a left axis and low voltage with electric alternation. Chest X-ray showed enlargement of the heart compared to previous radiographs.
An echocardiogram was ordered which confirmed the presence of a severe pericardial effusion with 'swinging heart' images and diastolic and systolic collapse of the right ventricule ( Figure 2 ). Pericardiocentesis obtained 300 ml of a turbid chylous fluid, which was unchanged by centrifugation. Biochemical analysis of the fluid showed high cholesterol levels (126 mg/dl), triglycerides (1307 mg/dl) and proteins (6.3 g/dl). Cytology showed 500 leucocytes/mm 3 , with 90% of mononuclear forms corresponding to small sized lymphocytes. No atypical cells were present and culture results were negative.
The patient improved after drainage of the fluid. He fasted and started on total parenteral nutrition. A thoracic CT image was performed which showed a 75% decrease in the size of the initial mediastinal mass. There were low density areas in the mass suggestive of necrosis. A small amount of pericardial fluid persisted, but no pleural effusion was seen ( Figure 3) .
After five days the dyspnoea recurred and a new echocardiogram confirmed the reaccumulation of fluid with haemodynamic disturbances. A pleuropericardial window was carried out with resection of the residual mediastinal mass.
An ample area of the anterior pericardial wall was resected and chylous fluid evacuated. Pathological exam of the mediastinal mass revealed only fibrosis.
Unfortunately, bleeding occurred from the innomi- Figure 3 . Thoracic CT scan with pericardial effusion.
nate vein and vena cava connection. The haemorrhage, due to intense fibrosis in the surrounding tissues, could not be controlled and it was necessary to put a pericardial patch in place. After 11 days the patient died in the Intensive Care Unit of respiratory insufficiency and Pseudomonas aeruginosa infection.
Discussion
In autopsy series of cancer patients the incidence of cardiac involvement by neoplasms has varied from 0.1% to 21%. Pericardium is the most common site (45%), followed by myocardium (32%). Both structures are involved in 22% of cases [2] . Occasionally the heart is not affected by the tumor itself but by drugs (doxorubicin, high dose cyclophosphamide), infections, hypothyroidism, radiation or unknown causes. Primary tumors of the heart (fibrosarcoma, malignant teratomas, mesotheliomas and angiosarcomas) may also involve the pericardium. Nevertheless, metastases are, by far, the most common cause of neoplastic pericarditis. Lung cancer is the most common primary tumor (35% of these patients have pericardial metastasis at autopsy). When the initial clinical picture of cancer is pericardial effusion [3] , 61% of the cases are due to carcinoma of the lung (40% adenocarcinoma). Haematologic neoplasms and breast cancer follow in frequency. The first case of isolated chylopericardium was described in 1888 by Hasebrock [4] after he found chylous fluid in the autopsy of a patient whose death had been caused by aspiration. In 1935, Yater [5] described the association between chylopericardium and chylothorax, while Groves and Effler [6] were the first to introduce the term 'primary chylopericardium' in 1954. Up to now, less than 90 cases of isolated chylopericardium have been reported in the literature. The present case is the first directly related to a mediastinal mass of neoplastic origin.
Aetiopathogenesis
The lymphatic vessels of the pericardium drain toward the anterior mediastinum and bronchopulmonary lymph nodes and finally into the thoracic duct. This is the main route ( Figure 4 ) but there are other diaphragmatic and intercostal routes [7] . Anatomical variants are found in 25% of the cases studied by autopsy or lymphangiography [8] . Due to valves in lymphatic vessels, reflux does not take place unless the pressure is greater than 15 cm of water [9] . Experimentally it has been shown that a blockade of the thoracic duct does not by itself cause chylopericardium. This is due to the presence of the several collateral pathways and their connection with the venous system (azigos vein and superior vena cava) [10] . Furthermore, review of cases of chylopericardium caused by benign tumors (hamartomas and lymphangiomas) [11] [12] [13] [14] make it evident that mechanical obstruction of venous drainage plays an important role in the pathophysiology of the disease. Three mechanisms can explain pericardial metastases: a) direct extension as in lung or oesophageal cancer, b) haematogenous spread such as in lymphoma, leukemia or melanoma and c) lymphatic spread, seen in breast or lung cancer. In the latter situation, mediastinal lymph nodes are usually involved and there is retrograde spread to lymphatic vessels of the heart and pericardium with small implants in the epicardial surface. There is no relationship between the tumor mass in the pericardium and the volume of the effusion.
Symptoms
In most of the cases in the literature (44%), patients are asymptomatic at diagnosis and the chylopericardium is detected by a chest X-ray showing the presence of cardiomegaly. Some patients have dyspnoea (39%), cough (10%), palpitations (3%) or thoracic pain (3%). Up to 17% may present with cardiac tamponade.
These signs and symptoms are not different from those observed in malignant effusions. In the latter cases overt metastatic disease is the general rule.
Diagnosis
Radiology and ultrasonography do not differentiate between chylopericardium and malignant pericardial effusions. The final diagnosis is determined by pericardiocentesis and analysis of the fluid. The milky appearance and finding of fat drops, seen by microscopy or SUDAN III stain, are typical. From a biochemical viewpoint chylopericardium is characterized by cholesterol levels higher than 100 mg/dl, triglycerides over 1000 mg/dl, and protein levels higher than 3.5 g/dl, although these levels are dependent on the patient's diet. The cells found in the fluid are leukocytes and, in general, do not exceed 4000/mm 3 with the proportion of lymphocytes being higher than 90%. Culture is negative [15] .
Different techniques have been used to demonstrate the relationship between the pericardial sac and the lymphatic system. In the 1950s a SUDAN III stained oil was administered orally for assessment of the latter in extracted pericardial fluid. The use of oral I 131 labeled trioleina opened new horizons [16] , and the combination of lymphangiography with computerized axial tomography has been of great importance for evaluating affected structures and possible abnormalities in the thoracic duct [17] .
In malignant effusions, the fluid is serosanguineous, or is a haemorrhagic exudate. Cytology is positive for cancer in only 70%-90% of cases [2] . Negative cytology results after irradiaton are common in patients with pericardial effusion secondary to lymphoma
Treatment
Treatment of chylopericardium is aimed at the prevention of tamponade or secondary constrictive pericarditis [18] and is designed to avert the metabolic, nutritional and immunological damage which occurs after a severe lymphatic loss. Therapeutic protocols usually begin with a diet rich in medium chain triglycerides which are directly absorbed into the portal venous system in order to reduce the amount of lymph ascending into the thoracic lymphatics. Evacuation of chylopericardium by repeated pericardiocentesis or with a pericardiostomy tube is effective in less than 50% of the cases.
Chylopericardium, due to mediastinal masses, is even more refractory to these conservative measures than effusions secondary to cardiac surgery. For this reason, surgery is recommended even in asymptomatic patients within two weeks after diagnosis [19] .
Hargus et al. [20] suggested that the indications for surgery in recurrent chylothorax could also be accepted in the treatment of the chylopericardium. These indications included: continuous drainage for seven to 10 days, nutritional problems or cardiac tamponade. The surgical technique with the lowest recurrence rate is a pericardial window with ligature and partial resection of the thoracic duct. Akamatsu et al. [21] favors a left thoracotomy because the thoracic duct has its main course in the left hemithorax, the time required for surgery is shorter and the possibilities of damaging the oesophagus and descending aorta are smaller. Moreover, they recommend ligature of the thoracic duct as close as possible to the diaphragm because re-accumulation of fluid is less frequent following this technique. However, in patients with chylopericardium associated with chylothorax the approach should always be performed on the side of pleural effusion. Chan et al. [22] have carried out pericardioperitoneal shunts in four patients, while in October 1996 Furret et al. [23] published the first case treated by thoracoscopy. The results with these novel techniques have been satisfactory, and could be considered as a step prior to thoracotomy. Further studies are needed to validate these preliminary observations.
In the case of patients who refuse surgery, radiotherapy is an appropriate alternative. Dajee and Woodhouse [24] administered 2000 cGy, fractionated into 10 doses, to a patient diagnosed with lymphangiomatosis of the mediastinum, who developed a chylothorax and chylopericardium refractory to conservative methods. After 12 months of follow-up the patient was asymptomatic.
The use of sclerosing agents such as tetracycline or bleomycin has caused constrictive pericarditis and are therefore not usually recommended.
In malignant pericardial effusions, the therapeutic approach depends on the type of tumor and its systemic spread. It is not only a local problem, as in the case of chylopericardium. The median survival after diagnosis of a malignant pericardial effusion is 3.5 months in the case of lung cancer, between nine and 18 months in breast cancer and 10 months in lymphoma [2] . If the patient is asymptomatic and the tumor is considered to be sensitive to chemotherapy, systemic therapy will be the treatment of choice, and serial echocardiograms should be performed to assess response. If there is cardiac tamponade, emergency pericardiocentesis with placement of a catheter followed by systemic therapy is indicated. In breast cancer, the use of hormonal therapy in these cases is not recommended because of the low and, especially, slow response.
Endocavitary instillation of sclerosing agents such as tetracyclines, often needs to be repeated several times to be effective, but 80% of the cases show response. Intrapericardial use of chemotherapy (bleomycin, cisplatin, vinblastine) is less effective and myelosuppression is a concern [2] .
Local radiotherapy has been used in the past with good results in haematological neoplasms, but at present, chemotherapy is the treatment of choice when the tumor is likely to be sensitive. No more than 4000 cGy should be administered to the heart so as to avoid myocardial toxicity.
When these conservative measures are no longer effective surgery is indicated. Subxifoid pericardiostomy is associated with low morbidity and a high rate of success. Relapse does occur up to 13% [2] of cases. Thoracotomy with subtotal pericardiectomy is reserved for constrictive pericarditis secondary to irradiation and for some rapidly relapsing malignant effusions not controlled by other therapies.
Conclusion
Chylopericadium is a rare entity diagnosed only after examination of the pathology fluid. Response to conventional treatment is unusual and a surgical approach should be considered early to avert development of cardiac tamponade. A pleuro-pericardial window with ligature of the thoracic duct is the treatment of choice.
